Sensor systems, devices, and methods for continuous glucose monitoring

US10327686B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10327686-B2
Application numberUS-201514980241-A
CountryUS
Kind codeB2
Filing dateDec 28, 2015
Priority dateDec 28, 2015
Publication dateJun 25, 2019
Grant dateJun 25, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Electrochemical impedance spectroscopy (EIS) may be used in conjunction with continuous glucose monitoring (CGM) to enable identification of valid and reliable sensor data, as well implementation of Smart Calibration algorithms.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for real-time calibration of a glucose sensor for measuring the level of glucose in a body of a user, said glucose sensor including physical sensor electronics, a microcontroller, and a working electrode, the method comprising: (a) performing, by said microcontroller, an electrochemical impedance spectroscopy (EIS) procedure to obtain imaginary impedance values for said working electrode; (b) calculating, by said microcontroller, a reference range associated with said values of imaginary impedance, said range being a function of the difference between the current imaginary impedance value and prior imaginary impedance values, wherein said reference range is calculated according to the relation range=3×median(|x i −x j |), wherein j represents the current imaginary impedance value, and i represents the most recent 2 hours of imaginary impedance values; (c) comparing, by the microcontroller, the current value of imaginary impedance to the reference range; (d) based on said comparison, determining, by the microcontroller, a time interval until the next calibration; and (e) setting, by the microcontroller, an alarm for performing said next calibration within said time interval based on said comparison. 2. The method of claim 1 , wherein said imaginary impedance values are filtered imaginary impedance values. 3. The method of claim 1 , wherein said imaginary impedance values are 1 kHz imaginary impedance values. 4. The method of claim 1 , wherein the reference range is clipped to be between 50Ω and 100Ω. 5. The method of claim 1 , wherein, said imaginary impedance values are filtered 1 kHz imaginary impedance values. 6. The method of claim 5 , wherein, if the current filtered 1 kHz imaginary value is outside of the reference range, the time interval until the next calibration is set at 6 hours from the most-recent calibration.

Assignees

Inventors

Classifications

  • invasive, e.g. introduced into the body by a catheter · CPC title

  • for measuring glucose, e.g. by tissue impedance measurement · CPC title

  • Measuring body composition by impedance, e.g. tissue hydration or fat content · CPC title

  • using visual displays (displays for heart-related electrical signals, e.g. ECG, A61B5/339) · CPC title

  • Details of analogue processing, e.g. isolation amplifier, gain or sensitivity adjustment, filtering, baseline or drift compensation (input circuits for detecting, measuring, or recording bioelectric or biomagnetic signals A61B5/30; specific diagnostic methods using bioelectric or biomagnetic signals A61B5/316) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10327686B2 cover?
Electrochemical impedance spectroscopy (EIS) may be used in conjunction with continuous glucose monitoring (CGM) to enable identification of valid and reliable sensor data, as well implementation of Smart Calibration algorithms.
Who is the assignee on this patent?
Medtronic Minimed Inc
What technology area does this patent fall under?
Primary CPC classification A61B5/14532. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).